Sign up
Pharma Capital

SkinBioTherapeutics' Dr Cath O'Neill named one of healthcare's top movers and shakers

Dr Cath O'Neill, chief executive of SkinBioTherapetics PLC (LON:SBTX), caught up with Proactive Investors after being recognised as one of the top 50 female leaders in UK healthcare as part of BioBusiness' 2017 50 Movers and Shakers report.

Dr O'Neill's been recognised for her research within the skin microbiome sector.

 

View full SBTX profile

SkinBioTherapeutics PLC Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.